<DOC>
	<DOCNO>NCT01505842</DOCNO>
	<brief_summary>Patients longstanding ulcerative colitis crohn 's disease large bowel increase risk develop cancer . The purpose study determine visualize mucosa detail use dye spray ( indigo-carmine ) result detection abnormality conventional colonoscopy without dye spray .</brief_summary>
	<brief_title>Chromoendoscopy Dysplasia Detection Chronic Inflammatory Bowel Disease</brief_title>
	<detailed_description>Background : Patients ulcerative colitis Crohn 's colitis increase risk colon cancer . The usefulness chromoendoscopy debate . Previous study either base magnify endoscopy non-randomized trial . Some guideline recommend chromoendoscopy target biopsy normal colonoscopy 40 random biopsy . Chromoendoscopy ability identify subtle lesion otherwise miss standard endoscopy . Whether chromoendoscopy target biopsy replace standard colonoscopy random biopsy surveillance patient chronic colitis unknown . Aim : In RCT surveillance colonoscopy patient ulcerative colitis Crohn 's colitis , determine chromoendoscopy use dilute solution Indigo-carmine improve dysplasia detection rate compare colonoscopy without chromoendoscopy . Methods : After informed consent patient undergoing surveillance colonoscopy randomize examined study control method . The study method employ 0.2-0.5 % Indigo-Carmine solution spray colonic rectal mucosa . The control method colonoscopy without Indigo-Carmine chromoendoscopy . In study arm control arm subject 32 random biopsy take ( 4 8 defined segment colon ) biopsies suspicious mucosa .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<criteria>Patients ulcerative colitis Crohn 's colitis satisfy criterion surveillance colonoscopy : Ulcerative colitis , extensive &gt; 8 year OR Crohn 's colitis involve â‰¥ 1/3 colon/rectum history PSC history previous dysplasia colon biopsy family history colon cancer first degree relative Patients decline participate Unable give inform consent Increased risk bleeding ( i.e . Warfarin , bleed disorder , Clopidogrel )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Ulcerative colitis</keyword>
	<keyword>Crohn 's disease</keyword>
	<keyword>Chromoendoscopy</keyword>
	<keyword>Dysplasia</keyword>
	<keyword>Neoplasia</keyword>
	<keyword>Inflammatory Bowel Disease</keyword>
</DOC>